— Why it moved
Why BJDX Stock Nearly Quadrupled Today — June 2, 2026
A manufacturing partnership press release met a 2.4M-share float, ran Bluejay from $2.17 to $8.48 before the bell, and half the peak was gone by the close.
What moved BJDX stock
Bluejay Diagnostics is a clinical-stage diagnostics company behind the Symphony sepsis-testing platform. It announced a strategic manufacturing partnership with Argonaut Manufacturing Services for Symphony — a scale-up press release with no revenue attached.
The mechanics
A ~$2M market cap with a 2.35M-share float is about as small as a listed company gets. One headline plus scanner attention turned that float into a slingshot: 74M shares traded against a 55K daily average, meaning the float changed hands roughly 31 times.
BJDX by the numbers
The alert window
Stock Pulse alerted premarket at 6:52 AM at $6.95; the peak $8.48 printed at 7:18 AM — twenty-six minutes of window, worth 22%, on real volume. That 7:18 AM print was the high of the entire day.
How BJDX's move ended
The regular session never traded above $7.00, and it closed at $4.31 — 38% below the alert, and half off the peak. Symphony is still in clinical development, and Bluejay has leaned on reverse splits to hold its listing. On a 2M-share float that has already run from $2.17 to $8.48 before the bell, the premarket blowoff is very often the high for the whole day.